Harvard Bioscience (HBIO) Curent Deferred Tax Liability (2014 - 2015)

Harvard Bioscience's (HBIO) quarterly Curent Deferred Tax Liability came in at $2.2 million in Q4 2015, up 1756.2% year-on-year from $121000.0 in Q4 2014, and up 820.49% on a QoQ basis from $244000.0 in Q3 2015.

Harvard Bioscience (HBIO) Curent Deferred Tax Liability (2014 - 2015) Analysis & Trends

Harvard Bioscience (HBIO) has 2 years of Curent Deferred Tax Liability data on file, last reported at $2.2 million in Q4 2015.

  • On a quarterly basis, Curent Deferred Tax Liability rose 1756.2% year-over-year to $2.2 million in Q4 2015; TTM through Dec 2015 was $2.2 million, a 1756.2% increase from a year earlier, with the FY2015 full-year figure at $2.2 million, up 1756.2% from the prior year.
  • Curent Deferred Tax Liability for Q4 2015 stood at $2.2 million, up from $244000.0 in the prior quarter.
  • Over the last five years, Curent Deferred Tax Liability for HBIO reached as high as $2.2 million in Q4 2015 and fell as low as $121000.0 in Q4 2014.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Alcon 32,734,969.19 Bn 32,734,967.53 Bn 1.53 Bn -
2 Intuitive Surgical 117.50 Bn 112.41 Bn 1.96 Bn -
3 Becton Dickinson 42.93 Bn 42.11 Bn 2.15 Bn -
4 Medline 30.82 Bn 36.66 Bn 1.84 Bn -
5 Resmed 27.90 Bn 26.23 Bn 890.98 Mn -
6 West Pharmaceutical Services 26.76 Bn 26.23 Bn 329.20 Mn -
7 Cooper Companies 15.30 Bn 15.16 Bn 735.40 Mn -
8 Solventum 13.46 Bn 12.90 Bn 1.10 Bn -
9 Align Technology 12.02 Bn 10.96 Bn 736.59 Mn -
10 Harvard Bioscience 28.05 Mn 20.96 Mn 12.24 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2015 2.25 Mn
Dec 31, 2015 2.25 Mn
Sep 30, 2015 244,000.00
Sep 30, 2015 244,000.00
Jun 30, 2015 246,000.00
Jun 30, 2015 246,000.00
Mar 31, 2015 239,000.00
Mar 31, 2015 239,000.00
Dec 31, 2014 121,000.00
Dec 31, 2014 121,000.00